Hyperhydration with cisplatin does not influence pemetrexed exposure

N. de Rouw; H.J. Derijks; L.B. Hilbrands; R.J. Boosman; B. Piet; S.L.W. Koolen; J.A. Burgers; A.M.C. Dingemans; M.M. van den Heuvel; L.E.L. Hendriks; J.G.J.V. Aerts; S. Croes; R.H.J. Mathijssen; A.D.R. Huitema; D.M. Burger; B. Biesma; R. ter Heine

doi:10.1111/bcp.15031

Hyperhydration with cisplatin does not influence pemetrexed exposure

N. de Rouw^*, H.J. Derijks, L.B. Hilbrands, R.J. Boosman, B. Piet, S.L.W. Koolen, J.A. Burgers, A.M.C. Dingemans, M.M. van den Heuvel, L.E.L. Hendriks, J.G.J.V. Aerts, S. Croes, R.H.J. Mathijssen, A.D.R. Huitema, D.M. Burger, B. Biesma, R. ter Heine

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	871-876
Number of pages	6
Journal	British Journal of Clinical Pharmacology
Volume	88
Issue number	2
Early online date	26 Aug 2021
DOIs	https://doi.org/10.1111/bcp.15031
Publication status	Published - Feb 2022

Keywords

hyperhydration
pemetrexed
pharmacokinetics
MALIGNANT PLEURAL MESOTHELIOMA
PHASE-I
CANCER

Access to Document

10.1111/bcp.15031Licence: CC BY-NC

Cite this

de Rouw, N., Derijks, H. J., Hilbrands, L. B., Boosman, R. J., Piet, B., Koolen, S. L. W., Burgers, J. A., Dingemans, A. M. C., van den Heuvel, M. M., Hendriks, L. E. L., Aerts, J. G. J. V., Croes, S., Mathijssen, R. H. J., Huitema, A. D. R., Burger, D. M., Biesma, B., & ter Heine, R. (2022). Hyperhydration with cisplatin does not influence pemetrexed exposure. British Journal of Clinical Pharmacology, 88(2), 871-876. https://doi.org/10.1111/bcp.15031

de Rouw, N. ; Derijks, H.J. ; Hilbrands, L.B. ; Boosman, R.J. ; Piet, B. ; Koolen, S.L.W. ; Burgers, J.A. ; Dingemans, A.M.C. ; van den Heuvel, M.M. ; Hendriks, L.E.L. ; Aerts, J.G.J.V. ; Croes, S. ; Mathijssen, R.H.J. ; Huitema, A.D.R. ; Burger, D.M. ; Biesma, B. ; ter Heine, R. / Hyperhydration with cisplatin does not influence pemetrexed exposure. In: British Journal of Clinical Pharmacology. 2022 ; Vol. 88, No. 2. pp. 871-876.

@article{86623c21aa074792813fde661a1620bd,

title = "Hyperhydration with cisplatin does not influence pemetrexed exposure",

keywords = "hyperhydration, pemetrexed, pharmacokinetics, MALIGNANT PLEURAL MESOTHELIOMA, PHASE-I, CANCER",

author = "{de Rouw}, N. and H.J. Derijks and L.B. Hilbrands and R.J. Boosman and B. Piet and S.L.W. Koolen and J.A. Burgers and A.M.C. Dingemans and {van den Heuvel}, M.M. and L.E.L. Hendriks and J.G.J.V. Aerts and S. Croes and R.H.J. Mathijssen and A.D.R. Huitema and D.M. Burger and B. Biesma and {ter Heine}, R.",

year = "2022",

month = feb,

doi = "10.1111/bcp.15031",

language = "English",

volume = "88",

pages = "871--876",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

number = "2",

}

de Rouw, N, Derijks, HJ, Hilbrands, LB, Boosman, RJ, Piet, B, Koolen, SLW, Burgers, JA, Dingemans, AMC, van den Heuvel, MM, Hendriks, LEL, Aerts, JGJV, Croes, S, Mathijssen, RHJ, Huitema, ADR, Burger, DM, Biesma, B & ter Heine, R 2022, 'Hyperhydration with cisplatin does not influence pemetrexed exposure', British Journal of Clinical Pharmacology, vol. 88, no. 2, pp. 871-876. https://doi.org/10.1111/bcp.15031

Hyperhydration with cisplatin does not influence pemetrexed exposure. / de Rouw, N.; Derijks, H.J.; Hilbrands, L.B.; Boosman, R.J.; Piet, B.; Koolen, S.L.W.; Burgers, J.A.; Dingemans, A.M.C.; van den Heuvel, M.M.; Hendriks, L.E.L.; Aerts, J.G.J.V.; Croes, S.; Mathijssen, R.H.J.; Huitema, A.D.R.; Burger, D.M.; Biesma, B.; ter Heine, R.

In: British Journal of Clinical Pharmacology, Vol. 88, No. 2, 02.2022, p. 871-876.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Hyperhydration with cisplatin does not influence pemetrexed exposure

AU - de Rouw, N.

AU - Derijks, H.J.

AU - Hilbrands, L.B.

AU - Boosman, R.J.

AU - Piet, B.

AU - Koolen, S.L.W.

AU - Burgers, J.A.

AU - Dingemans, A.M.C.

AU - van den Heuvel, M.M.

AU - Hendriks, L.E.L.

AU - Aerts, J.G.J.V.

AU - Croes, S.

AU - Mathijssen, R.H.J.

AU - Huitema, A.D.R.

AU - Burger, D.M.

AU - Biesma, B.

AU - ter Heine, R.

PY - 2022/2

Y1 - 2022/2

KW - hyperhydration

KW - pemetrexed

KW - pharmacokinetics

KW - MALIGNANT PLEURAL MESOTHELIOMA

KW - PHASE-I

KW - CANCER

U2 - 10.1111/bcp.15031

DO - 10.1111/bcp.15031

M3 - Article

C2 - 34374116

VL - 88

SP - 871

EP - 876

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 2

ER -